Results 91 to 100 of about 16,181 (154)

Peripheral Sympathetic Sprouting Drives Neuropathic Pain via Spinal Microglial P2Y12 Activation in a Rat Spinal Nerve Ligation Model. [PDF]

J Pain Res
Yu T, Huang H, Li Z, Yan H.
europepmc   +1 more source

Cost-Effectiveness of Pharmacogenomics-Guided Treatment in Cardiovascular Disease: An Umbrella Review. [PDF]

Pharmgenomics Pers Med
Janković SM, Milosavljević M, Stević I, Ašić A, Jusić A, Devaux Y, Belančić A, Bektay MY, Pejčić AV.   +8 more
europepmc   +1 more source

Egyptian Society of Cardiology national advisory statement revisiting antiplatelet therapy: insights from E. S. C. 2025 hot-line trials. [PDF]

Egypt Heart J
Shaheen S, Shokry K, Shawky I, Kabil H, Nasr G, Abd Elghany M, Mokarrab M, Abd Elhady Y, Zareef B, Soliman H, Zahran M, Abd Elhameed M.   +11 more
europepmc   +1 more source

The evolution of dual antiplatelet therapy in patients with coronary artery disease. [PDF]

Eur Heart J Open
Simonsson M, James S, Ten Berg JM, Gigante B.   +3 more
europepmc   +1 more source

In silico repurposing of clinically approved drugs as potential BRAF inhibitors: a pharmacophore-based virtual screening and experimental investigation. [PDF]

Cancer Cell Int
Amini H, Ebrahimi N, Mousavirahimi S, Zamani M, Bagherzadeh K, Montazeri H, Azizian H.   +6 more
europepmc   +1 more source

Antithrombotic Strategies After Complex Percutaneous Coronary Intervention. [PDF]

J Clin Med
Ueki Y, Kuwahara K.
europepmc   +1 more source

Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention of the Left Main Coronary Artery: A Contemporary Narrative Review. [PDF]

Medicina (Kaunas)
Brie DM, Mornoș C, Popescu R, Brie AD.
europepmc   +1 more source

Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials. [PDF]

Stroke Vasc Neurol
Yang Y, Zhu J, Gao Y, Pan Y, Wang Y.
europepmc   +1 more source